Goldberg SL, Chedid S, Jennis AA, Preti RA. 2000. Unrelated cord blood transplantation in adults: A single institution experience. Blood 96:208a.

Grewal SS, Barker JN, Davies SM, Wagner JE. 2003. Unrelated donor hematopoietic cell transplantation: Marrow or umbilical cord blood? Blood 101(11):4233–4244.


Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG. 1993. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New England Journal of Medicine 328(9):593–602.

Kurtzberg J, Scaradavou M, Wagner J, et al. 2000. Banked umbilical cord blood is an excellent source of donor hematopoietic stem cells for infants with malignant and nonmalignant conditions lacking a related donor. Blood 96:587a.


Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, Kurtzberg J. 2001. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. New England Journal of Medicine 344(24):1815–1822.

Linch DC, Brent L. 1989. Marrow transplantation. Can cord blood be used? Nature 340(6236):676.

Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, Messina C, Ortega J, Badell-Serra I, Plouvier E, Souillet G, Jouet JP, Pasquini R, Ferreira E, Garnier F, Gluckman E. 1999. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 93(11): 3662–3671.


Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K. 1992. Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 80(7):1838–1845.

NetCord. 2005. NetCord By-Laws. [Online] Available: https://www.netcord.org/netcord_bylaws.pdf [accessed January 2005].

NMDP (National Marrow Donor Program). 2004. 2003 Report to the Community. [Online] Available: http://www.marrow.org/NMDP/report_to_community03.pdf [accessed January 2005].


Rocha V, Arcese W, Sanz G. 2000. Prognostic factors of outcome after unrelated cord blood transplantation. Blood 96:567a.

Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE. 1998. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New England Journal of Medicine 339(22):1565–1567.


Stevens CE. 2004. Unrelated cord blood for transplantation: Collections and processing. Presentation at the meeting of the Committee on Establishing a National Cord Blood Stem Cell Bank Program, Meeting 2, August 18, 2004, Beckman Center, Irvine, CA.


Thomson BG, Robertson KA, Gowan D, Heilman D, Broxmeyer HE, Emanuel D, Kotylo P, Brahmi Z, Smith FO. 2000. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 96(8):2703–2711.


Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NKC, Davies SM. 2002. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100(5):1611–1618.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement